Eastwood Bio-Medical Canada Inc. (EWOOF)
USD 0.69
(-42.19%)
USD 0.69
(-42.19%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -12.16 Thousand | -3150.94 | -93.79 Thousand | -407.01 Thousand | -135.52 Thousand | -454.79 Thousand |
| Net Income | -393.83 Thousand | -109.98 Thousand | -487.15 Thousand | -639.31 Thousand | -439.24 Thousand | -861.97 Thousand |
| Depreciation & Amortization | 77.7 Thousand | 78.4 Thousand | 84.98 Thousand | 79.3 Thousand | 34.99 Thousand | 25.61 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 300.91 Thousand | 25.02 Thousand | 317.94 Thousand | 137.78 Thousand | 194.61 Thousand | 67.66 Thousand |
| Other non-cash items | 3040.00 | 3398.06 | -9573.00 | 15.2 Thousand | 74.11 Thousand | 313.9 Thousand |
| Investing Cash Flow | - | -2205.07 | -4498.78 | - | -17.58 Thousand | 10 Thousand |
| Investments in PPE | -1.44 | -2205.07 | -4498.78 | - | -17.58 Thousand | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | 10 Thousand |
| Financing Cash Flow | -3244.50 | 19.27 Thousand | 16.14 Thousand | 29.99 Thousand | - | 10 Thousand |
| Debt repayment | -3244.50 | -19.27 Thousand | -20 Thousand | -40 Thousand | - | -7596.36 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | 38.55 Thousand | 16.14 Thousand | 29.99 Thousand | - | - |
| Accounts receivables | 89.34 | -6286.46 | 2966.09 | 51.38 Thousand | 110.95 Thousand | -306.12 Thousand |
| Accounts payables | 29.84 Thousand | 5369.21 | -5196.11 | 13.74 Thousand | 6504.36 | 12.83 Thousand |
| Inventory | -0.34 | 0.25 | 0.02 | 1.00 | - | - |
| Other working capital | 270.98 Thousand | 25.94 Thousand | 320.17 Thousand | 72.65 Thousand | 77.15 Thousand | -580.00 |
| Cash at beginning of period | 29.23 Thousand | 16.84 Thousand | 91.99 Thousand | 475.78 Thousand | 629.42 Thousand | 1.27 Million |
| Cash at end of period | 13.29 Thousand | 29.23 Thousand | 16.84 Thousand | 91.99 Thousand | 475.78 Thousand | 826.59 Thousand |
| Capital Expenditure | -1.44 | -2205.07 | -4498.78 | - | -17.58 Thousand | - |
| Effect of forex changes on cash | - | -0.92 | -0.32 | - | - | - |
| Net cash flow / Change in cash | -15.94 Thousand | 12.39 Thousand | -75.14 Thousand | -383.79 Thousand | -153.63 Thousand | -444.79 Thousand |
| Free Cash Flow | -12.16 Thousand | -5356.01 | -98.29 Thousand | -407.01 Thousand | -153.1 Thousand | -454.79 Thousand |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -115.57 Thousand | -130.11 Thousand | -54.23 Thousand | -132.74 Thousand | -393.83 Thousand | -88.9 Thousand |
| Depreciation & Amortization | 26.63 Thousand | 26.63 Thousand | 26.63 Thousand | 19.42 Thousand | 77.7 Thousand | 20.43 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 62.09 Thousand | 105.67 Thousand | 15.98 Thousand | 132.19 Thousand | 300.91 Thousand | 59.3 Thousand |
| Other non-cash items | 9266.00 | 9267.00 | 10.38 Thousand | -16.99 Thousand | 3040.00 | 7023.66 |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 22.4 Thousand | -9304.00 | -11.19 Thousand | -2964.22 | -3244.50 | -5856.29 |
| Debt repayment | -22.4 Thousand | -9304.00 | -8324.16 | -3244.50 | -3244.50 | -7727.00 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 22.4 Thousand | -9304.00 | -11.19 Thousand | 280.28 | - | -5856.29 |
| Accounts receivables | -3653.00 | 3847.00 | -23.17 Thousand | 7446.57 | 89.34 | -11.78 Thousand |
| Accounts payables | -21.4 Thousand | 40.43 Thousand | -10.37 Thousand | -6308.15 | 29.84 Thousand | 5353.81 |
| Inventory | - | - | 23.17 Thousand | 0.58 | -0.34 | 0.19 |
| Other working capital | 21.05 Thousand | -2930.00 | 26.35 Thousand | 131.05 Thousand | 270.98 Thousand | 65.73 Thousand |
| Cash at beginning of period | 8190.00 | 6024.00 | 18.44 Thousand | 15.11 Thousand | 29.23 Thousand | 22.49 Thousand |
| Cash at end of period | 13.01 Thousand | 8190.00 | 6024.00 | 13.29 Thousand | 13.29 Thousand | 15.11 Thousand |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 4825.00 | 2166.00 | -12.42 Thousand | -1818.00 | -15.94 Thousand | -7386.00 |
| Free Cash Flow | -17.58 Thousand | 11.47 Thousand | -1234.00 | 1891.36 | -12.16 Thousand | -2143.34 |
000430
PHGE-UN
AFP
8TRA
FRE
015360